Wednesday 18 October 2017
Contact US    |    Archive
PR
6 days ago

FDA Grants Priority Review for Potential New Indication for Lilly s Verzenio™ (abemaciclib) as Initial Treatment of Advanced Breast Cancer

INDIANAPOLIS, Oct. 12, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that t

Read on the original site


The life of Sissi

- en.gmw.cn
Hashtags:   

FDA

 | 

Grants

 | 

Priority

 | 

Review

 | 

for

 | 

Potential

 | 

New

 | 

Indication

 | 

for

 | 

Lilly

 | 

Verzenio™

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
All Countries